World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access |
Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc |
Journal website http://www.wjon.org |
Case Report
Volume 6, Number 4, August 2015, pages 426-428
Posterior Reversible Encephalopathy Syndrome in a Bone Marrow Transplant Patient: A Complication of Immunosuppressive Drugs?
Table
Hypertensive encephalopathy |
Acute or chronic renal disease |
Toxemia of pregnancy |
Post-transplantation |
Allo-BMT |
Solid organ transplantation |
Infection/sepsis/shock |
Multiorgan dysfunction syndrome |
Autoimmune disease |
Systemic lupus erythematosus |
Wegener’s granulomatosis |
Polyarteritis nodosa |
Cryoglobulinemia |
Immunosuppressive, immunomodulatory, and chemotherapeutic drugs |
Bevacizumab |
Cisplatin and other platinum based agents |
Cyclosporin |
Tacrolimus |
Cytarabine |
Gemcitabine |
Interferon-alpha |
Intravenous immunoglobulin |
Ipilimumab |
Methotrexate |
Rituximab |
Tyrosine kinase inhibitors (pazopanib), sorafenib, sunitinib |
Vincristine |
Thrombotic thrombocytopenic purpura |
Hemolytic and uremic syndrome |
Miscellaneous reported associations |
Hypomagnesemia [8, 9] |
Hypercalcemia [10, 11] |
Hypocholesterolemia [12] |
Ephedra overdose |
Triple-H Therapy |
Tumor lysis syndrome |
Dialysis/erythropoietin syndrome |
Porphyria |
Contrast media exposure (cerebral, coronary angiography) |